T-cell activation involves two phases, enabling a more precise immune response. This insight may boost cancer immunotherapy ...

A team from the Max Planck Research Group for Systems Immunology at the University of Würzburg has identified a previously unknown phase of the immune response. The results, published in Science, ...

Nigel McCracken, chief operating officer, Virax Biolabs, discusses the expansion of its ViraxImmune platform into areas such as transplant monitoring, vaccine efficacy, latent virus reactivation, and ...

Patients with spastic paraplegia type 15 develop movement disorders during adolescence that may ultimately require the use of ...

A team of researchers from the University of Chicago, has identified a novel oncometabolite that accumulates in tumors and ...

NEW YORK – Marengo Therapeutics is expediting development of a novel class of T-cell engagers that promote expansion of specific sets of immune cells, betting that they will trigger a response that ...

A team has identified a previously unknown phase of the immune response. The results challenge long-standing assumptions about the process called 'T-cell priming'. These new insights have significant ...

Our body's own defense system not only clears away bacteria and viruses, it can also fight cancer. However, not all tumor ...

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.

Tolerogenic dendritic cells in the intestines are shown to reduce the immune responses caused by exposure to food proteins.